Improving Night Shift Nurses' Health and Reducing Burnout

January 18, 2026 updated by: Christopher Imes, University of Pittsburgh

A Pilot, Feasibility Study to Improve Night Shift Nurses' Health and Reduce Burnout

Healthy and happy nurses are essential to ensuring optimal patient outcomes and organizational success. The evidence on the negative impacts of night shift on nurses' health and cognitive function, and their implications on patient outcomes and organizational costs, reflect the need for interventions to mitigate these detrimental outcomes.

This pilot, feasibility, clinical trial will examine the feasibility of two fatigue countermeasure interventions (access to napping/relaxation room and use of blue/green light blocking glass during night shift) and explore the interventions effects on nurses' health, missed care, and burnout.

Study Overview

Detailed Description

Aim 1 (Primary): Examine the feasibility of a larger study and hospital-wide implementation of two fatigue countermeasure interventions (access to napping/relaxation rooms and use of blue/green light blocking glass during night shift).

Aim 2 (Exploratory): Explore the effects of the interventions on melatonin levels, overall health, sleep, fatigue, cognitive function, missed care, nurse burnout, and salivary melatonin levels.

Study Type

Interventional

Enrollment (Actual)

5

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15232
        • UPMC Shadyside

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being a registered nurse at UPMC Shadyside (Pittsburgh, PA)
  • Working full-time night or rotating shifts
  • Willing to wear a Fitbit around-the-clock during the study
  • Willing to use nap/relaxation room and glasses only when assigned to that condition
  • Willing to provide saliva samples

Exclusion Criteria:

  • Having a diagnosed sleep disorder (e.g., obstructive sleep apnea, insomnia, restless leg syndrome, or shift work disorder)
  • Currently being treated for a serious mental illness
  • Needing to use eye glasses to complete work related activities (note: contact lenses are acceptable)
  • Use of prescription or over-the-counter sleep aides including melatonin

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Single group, crossover - order of the interventions to be randomly selected

All participants will receive the same interventions which includes access to the napping/relaxation room only intervention, blue and green light blocking glasses only intervention, and the combined intervention. There will be a two-week washout between the interventions. The order of the interventions will be randomized to one of the following options:

  • Napping/relaxation room, blue and green light blocking glasses, combined
  • Blue and green light blocking glasses, napping/relaxation room, combined
  • Napping/relaxation room, combined, blue and green light blocking glasses
  • Blue and green light blocking glasses, combined, napping/relaxation room
  • Combined, napping/relaxation room, blue and green light blocking glasses
  • Combined, blue and green light blocking glasses, napping/relaxation room
During the night shift, study participants will have access to the hospital unit's napping/relaxation room with a sound machine, diffusers for aromatherapy, a massage chair that can be used for napping, and snacks.
During the night shift, participants will be asked wear study-provided blue and green light blocking glasses.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment rate
Time Frame: 2 months
Number of potential participants screened in order to enroll 8 participants
2 months
Attrition rate
Time Frame: 4 months
Percentage of enrolled participants completing the intervention as a whole and its three conditions
4 months
Completeness of questionnaire responses
Time Frame: 4 months
Percentage of completed responses
4 months
Melatonin collection
Time Frame: 4 months
Number of salivary melatonin samples collected
4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in physical health between baseline and the three conditions
Time Frame: 3 months

Changes the in PROMIS Global Health 10-item Measure, Physical Health sub-scale T-score.

T-score ranges from 16.2 to 67.7 with 50.0 (standard deviation of 10) being the population mean.

Higher scores represent better physical health.

3 months
Changes in mental health between baseline and the three conditions
Time Frame: 3 months

Changes the in PROMIS Global Health 10-item Measure, Mental Health sub-scale T-score.

T-score ranges from 21.2 to 67.6 with 50.0 (standard deviation of 10) being the population mean.

Higher scores represent better mental health.

3 months
Changes in Multidimensional Sleep Health between baseline and the three conditions
Time Frame: 3 months
Changes in RSATED survey scores Total score ranges from 0 to 12 with higher scores representing better sleep health.
3 months
Changes in sleep distrubance between baseline and the three conditions
Time Frame: 3 months

Changes in PROMIS Sleep Disturbance 8-item Measure T-scores. T-score ranges from 28.9 to 76.5.7 with 50.0 (standard deviation of 10) being the population mean.

Higher scores represent more sleep disturbances.

3 months
Changes in sleep-related impairment between baseline and the three conditions
Time Frame: 3 months
Changes in PROMIS Sleep-related Impairment 8-item Measure T-scores. T-score ranges from 30.2 to 80.1 with 50.0 (standard deviation of 10) being the population mean. Higher scores represent more sleep-related impairment.
3 months
Change in sleep duration between baseline and the three conditions
Time Frame: 3 months
Change in mean actigraphic sleep duration
3 months
Change in sleep efficiency between baseline and the three conditions
Time Frame: 3 months
Change in mean actigraphic sleep efficiency
3 months
Change in fatigue between baseline and the three conditions
Time Frame: 3 months
Change in PROMIS Fatigue 7-item Measure T-scores. T-score ranges from 29.4 to 83.2 with 50.0 (standard deviation of 10) being the population mean. Higher scores represent more fatigue.
3 months
Change in cognition function between baseline and the three conditions
Time Frame: 3 months
Change in PROMIS Cognitive Function 8-item Measure T-scores. T-score ranges from 22.41 to 83.2 with 63.48 (standard deviation of 10) being the population mean. Higher scores represent better cognitive function.
3 months
Change in burnout between baseline and the three conditions
Time Frame: 3 months
Change in Copenhagen Burnout Inventory scores. The Copenhagen Burnout Inventory has three sub-scales measuring personal burnout, work-related burnout, and client-related burnout. Sub-scales scores range from 0 to 100 with higher scores representing greater burnout.
3 months
Changes in missed care between baseline and the three conditions
Time Frame: 3 months
Changes in Tasks Undone-12 Scale scores. Scores range from 0 to 12 with higher scores representing more undone nursing tasks.
3 months
Changes in salivary melatonin levels between baseline and the three conditions
Time Frame: 3 months
Changes in salivary melatonin levels
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 23, 2025

Primary Completion (Actual)

October 29, 2025

Study Completion (Actual)

December 31, 2025

Study Registration Dates

First Submitted

February 11, 2025

First Submitted That Met QC Criteria

February 11, 2025

First Posted (Actual)

February 17, 2025

Study Record Updates

Last Update Posted (Actual)

January 21, 2026

Last Update Submitted That Met QC Criteria

January 18, 2026

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Final data sets from the research may be shared.

IPD Sharing Access Criteria

A Limited Dataset (LDS) may be created and shared pursuant to a Data Use Agreement (DUA) appropriately limiting use of the dataset and prohibiting the recipient from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Access to napping/relaxation room

Subscribe